ArticleNucleic acids research2026
GENEasso: a curated resource of credible disease-gene associations across complex diseases from GWAS summary statistics.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ontology-driven association rule mining for biomedical entity relationships: integrating hierarchical knowledge to improve gene-disease discovery.Scientific reports · 2026Article
- The 2026 Nucleic Acids Research database issue and the online molecular biology database collection.Nucleic acids research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Gene-based association analysis has become a powerful strategy to improve the biological interpretability of genome-wide association studies (GWAS) by aggregating variant-level signals at the gene level. Although several transcriptome-wide association study (TWAS)-specific databases have been developed, TWAS represents only one class of gene-based association methods and relies primarily on expression-mediated effects, whereas other gene-based approaches also play critical roles in identifying disease-associated genes. To address this limitation, we present GENEasso, a comprehensive platform that integrates multiple gene-level statistical frameworks to enable robust exploration of disease-gene associations across complex diseases. GENEasso systematically applies seven representative methods to 8226 curated GWAS summary statistics, generating 716 122 high-confidence disease-gene associations. The platform supports cross-method consensus scoring, tissue-specific enrichment prioritization, and ancestry-stratified analyses across five populations. Results can be interactively explored through Manhattan plots and ontology-based navigation, with full transparency and unrestricted access to data. A web server module allows users to upload their own GWAS summary statistics, select gene-based methods, and benchmark their findings against the GENEasso reference database. Concordance across methods increases the credibility of associations, improving reproducibility and supporting user-defined gene prioritization workflows. GENEasso is freely available as an open-access resource at https://www.geneasso.net.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.